Stocks · Health care · Biological Products, (No Diagnostic Substances)

Cullinan Therapeutics, Inc.

CGEM Clue Score48
United States Fiscal year ends December CIK 0001789972 Results filed 6 Aug 2026

What the insiders did No buying or selling

By person

7 insiders · 0 transactions
12.0×

Nadim Ahmed holds 12.0 times base salary in stock. $8.43M of shares against $698.48K in salary for 2025.

Salary from the company's own proxy. The shares are what Nadim Ahmed last reported holding, valued at $21.57, the price Common Stock was last bought or sold at on the open market here, on 8 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Lynx1 Capital Management LP entity
10% owner
—
—
—
8,963,500
$193.34M
+26.4%
Nadim Ahmed
President and CEO
—
—
—
390,803
$8.43M
+43.9%
Corrine Savill
Chief Business Officer
—
—
—
240,990
$5.20M
+18.4%
Jeffrey Alan Jones
Chief Medical Officer
—
—
—
159,968
$3.45M
+34.8%
Jennifer Michaelson
Chief Scientific Officer
—
—
—
158,844
$3.43M
+44.5%
Jacquelyn L Sumer
Chief Legal Officer
—
—
—
130,559
$2.82M
+35.8%
Mary Kay Fenton
Chief Financial Officer
—
—
—
127,921
$2.76M
+6,293%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.